IRWD R&D to Revenue
Ironwood Pharma Inc Class A · R&D to Revenue
IRWD R&D to Revenue
Latest reported19.83%period ending
IRWD Quarterly R&D/Revenue (331.72% → 19.83%)
Latest values, visible window
High-resolution chart · PNG
IRWD r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 19.8344% | |
| 20.1838% | |
| 45.8257% | |
| 18.0182% | |
| 26.8727% | |
| 66.6748% | |
| 28.0424% | |
| 32.5651% | |
| 32.192% | |
| 34.4765% | |
| 30.3489% | |
| 28.379% | |
| 1,047.6858% | |
| 12.0708% | |
| 9.4273% | |
| 10.293% | |
| 11.4079% | |
| 11.0962% | |
| 26.8872% | |
| 10.5131% | |
| 11.6917% | |
| 20.6922% | |
| 13.9415% | |
| 20.9649% | |
| 23.969% | |
| 35.0587% | |
| 21.0109% | |
| 21.0045% | |
| 28.1348% | |
| 78.5538% | |
| 33.8751% | |
| 71.2389% | |
| 48.0014% | |
| 52.7872% | |
| 42.5834% | |
| 42.6893% | |
| 57.3843% | |
| 64.6053% | |
| 43.9543% | |
| 56.7664% | |
| 58.2925% | |
| 48.2148% | |
| 51.8262% | |
| 65.2734% | |
| 103.2584% | |
| 92.0814% | |
| 72.1824% | |
| 148.4927% | |
| 323.7135% | |
| 185.8542% | |
| 447.5452% | |
| 466.6667% | |
| 249.3325% | |
| 1,006.2366% | |
| 104.7924% | |
| 24.3256% | |
| 220.7477% | |
| 240.9373% | |
| 75.3374% | |
| 187.4693% | |
| 172.3406% | |
| 191.0228% | |
| 126.7947% | |
| 206.8882% | |
| 191.1945% | |
| 205.8882% | |
| 302.9754% | |
| 121.9309% | |
| 293.4493% | |
| 355.7064% | |
| 331.725% |